Hemostatic Devices
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 61/663,412, filed Jun 22, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,072,806 | Hemostatic Devices In force · High confidence | Teleflex Life Sciences II LLC | In force | High confidence | ||
| US 9,352,066 | Hemostatic Devices In force · High confidence | Teleflex Life Sciences II LLC | In force | High confidence | ||
| US 9,603,964 | Hemostatic Devices In force · High confidence | Teleflex Life Sciences II LLC | In force | High confidence | ||
| US 10,960,100 | Hemostatic Devices In force · High confidence | Teleflex Life Sciences II LLC | In force | High confidence | ||
| US 11,559,601 | Hemostatic Devices In force · High confidence | Teleflex Life Sciences II LLC | In force | High confidence | ||
| Application 18/158,039 | Hemostatic Devices Abandoned Abandoned Nov 16, 2026 | Teleflex Life Sciences II LLC | Abandoned | Abandoned Nov 16, 2026 |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Teleflex Life Sciences LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.